All posts by: Michael Zand

About Michael Zand

Creating ‘Re-Specified’ Stem Cells for Disease Modeling – Science Daily (press release)

Creating ‘Re-Specified’ Stem Cells for Disease ModelingScience Daily (press release)Oct. 3, 2013 — In a paper in Cell Stem Cell, a team led by researchers in the Boston Children’s Hospital’s Stem Cell Transplantation Program reports a new approach for turning induced pluripotent stem cells (iPSCs) into hematopoietic stem and … …read more   &nbs… Continue reading

2013-10-07 NEWS

BrainStorm to Present at 2013 Stem Cell Meeting on the Mesa Organized by … – Wall Street Journal

BrainStorm to Present at 2013 Stem Cell Meeting on the Mesa Organized by …Wall Street JournalBrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Dr. Adrian Harel, Director R&D, will present at the 3rd Annual Regen Med Partnering Forum, part of the … …read more   &nbs… Continue reading

2013-10-07 NEWS

Generating Human Induced Pluripotent Stem Cell Banks – Science Daily (press release)

Science Daily (press release)Oct. 3, 2013 — The ability to make induced pluripotent stem cells (iPSCs) from mature cells in the body holds great potential for improved drug screening, disease modeling, and medical treatments for numerous conditions. Establishing well …Stem Cells Engineered To Become Targeted Drug FactoriesRedOrbitBrainStorm to Present at 2013 Stem Cell Meeting on … Continue reading

2013-10-07 NEWS

BrainStorm to Present at 2013 Stem Cell Meeting on the Mesa Organized by … – DailyFinance

BrainStorm to Present at 2013 Stem Cell Meeting on the Mesa Organized by …DailyFinanceOrganized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM) and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three-day conference aimed at … …read more   &nbs… Continue reading

2013-10-07 NEWS

Hit-and-Run Action of Stem Cells Exploited for Targeted Drug Delivery – Genetic Engineering News

Hit-and-Run Action of Stem Cells Exploited for Targeted Drug DeliveryGenetic Engineering NewsScientists have inserted mRNA into mesenchymal stem cells (MSCs) to produce a drug-delivery vehicle. Following systemic administration, the modified MSCs targeted and adhered to sites of inflammation, then released interleukin-10 that significantly … …read more   &nbs… Continue reading

2013-10-07 NEWS